SHEENA RAY: Open Payments
NPI 1306280326 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $30 |
| ABBVIE INC. | 1 | $19 |
Products named: CAPLYTA, AUSTEDO XR, FANAPT, INGREZZA, REXULTI, Cologuard Collection Kit, VRAYLAR.
Industry payments across UT — which companies pay providers there.
